News

Allergic reactions to “alpha-gal” – a sugar found in the blood of many mammals – are on the rise, and it’s a phenomenon that has captured much recent media attention. Although alpha-gal in meat usually poses no problems for humans,…

Studies have suggested the prevalence of sesame allergies in the US is more than 0.1 percent, which is a similar rate to soy allergy or fish allergy. As the first step in the process of determining whether sesame will become…

The Allergen Bureau were represented at the recent food allergy meetings held in Copenhagen, Denmark by Kirsten Grinter (Allergen Bureau President and Regulatory, Scientific Affairs and Nutrition Manager at Nestle Oceania) and Dr Simon Brooke Taylor (Food Safety & Risk…

Allergists in Korea have explored one patient’s apparent anaphylactic reaction to Coca-Cola and reported what they believe to be the world’s first confirmed allergy to fructose. A young woman had experienced allergy symptoms and loss of consciousness after drinking Coca-Cola,…

Development of the world’s leading potential coeliac disease vaccine, Nexvax2®, has progressed, with the company ImmusanT Inc. initiating a Phase 2 study in people with coeliac disease living in Australia and New Zealand. The study aims to further assess safety,…

The Allergen Bureau is delighted to welcome Mondelēz International as a new Allergen Bureau Full Member organisation. Mondelēz International is a previous Full Member and we are grateful for their renewed commitment to this important food industry initiative. Mondelēz International…